Library
Pirovalerone
Pyrovalerone is classified as Norepinephrine–dopamine reuptake inhibitor (stimulant). It belongs to the Pyrrolidinophenone cathinone chemical class.
Also known as: O-2371, Beta-keto-prolintane, pirovalerone
Classification
- Chemical: Cathinone
- Psychoactive: Stimulant
Effects
- Stimulation
- Loss Of Appetite
- Dry Mouth
- Tremor
- Teeth Grinding
- Jaw Tension
- Anxiety
- Irritability
- Talkativeness
- Alertness Enhancement
- Light Sensitivity
Routes of Administration
Oral
Dosage
- Heavy: 100+ mg
- Light: 10–25 mg
- Common: 25–60 mg
- Strong: 60–100 mg
- Threshold: 5–10 mg
Duration
- Onset: 0.17-0.5 h
- Peak: 0.5-2 h
- Offset: 2-3 h
- After Effects: 2-24 h
- Total Duration: 3-6 h
Insufflated
Dosage
- Heavy: 80+ mg
- Light: 5–15 mg
- Common: 15–40 mg
- Strong: 40–80 mg
- Threshold: 3–5 mg
Duration
- Onset: 0.08-0.17 h
- Peak: 0.25-1 h
- Offset: 1-2.5 h
- After Effects: 2-24 h
- Total Duration: 2.5-5 h
Rectal
Dosage
- Heavy: 70+ mg
- Light: 5–15 mg
- Common: 15–35 mg
- Strong: 35–70 mg
- Threshold: 3–5 mg
Duration
No data available for this section yet.
Intravenous
Dosage
- Heavy: 30+ mg
- Light: 1–5 mg
- Common: 5–15 mg
- Strong: 15–30 mg
- Threshold: 0.5–1 mg
Duration
- Onset: 0.02-0.05 h
- Peak: 0.05-0.5 h
- Offset: 0.5-2 h
- After Effects: 2-24 h
- Total Duration: 2-4 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
No external data sources listed for this substance yet.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
